Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 2025Cell ProliferationOpen Access

Non‐Coding RNAs in Breast Cancer Radioresistance: Mechanisms, Functional Roles and Translational Potentials

View Full Paper
Ask AI
Bookmark
Share

Authors

XZXiaohui ZhaoYQYuting QiuJCJie Chen

Discussion

Loading...

Member takes

Overview

This review highlights how non-coding RNAs drive radioresistance mechanisms in breast cancer, suggesting new therapeutic approaches.

Key Points

  • Non-coding RNAs are crucial regulators of gene expression implicated in breast cancer radioresistance.
  • Mechanisms include regulating the cell cycle, DNA damage repair, and apoptosis, impacting treatment efficacy.
  • RNA-based therapies, such as siRNAs and CRISPR/Cas9, show promise for enhancing radiosensitivity, but face clinical challenges.
  • Advancements in nanoparticle delivery systems may improve the efficacy and safety of ncRNA-targeted therapies.

Cite This Study

Zhao et al. (2025) studied this question.

synapsesocial.com/papers/68d44f8331b076d99fa57099https://doi.org/10.1111/cpr.70119
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Functions and mechanisms of ncRNAs in breast cancer immunotherapy and targeted therapy2026
  2. 2Innovative therapeutic strategies to overcome radioresistance in breast cancer2024 · 3 citations
  3. 3Role of non-coding RNAs in radiotherapy sensitivity in non-small cell lung cancer2025
  4. 4Role of non-coding RNAs in radiotherapy sensitivity in non-small cell lung cancer2025
  5. 5Non-coding RNAs regulation in breast cancer pathogenesis2026 · 1 citations